Zusammenfassung
Das Kapitel behandelt die morphologische Erfassung der Tumorregression nach Chemotherapie oder Strahlenbehandlung. Die gebräuchlichen Tumorregressionsschemata werden dargestellt.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsLiteratur
Bässler R (1997) Mamma. In: Remmele W (ed) Pathologie. Springer, Berlin Heidelberg New York, pp 133–368
Carey LA, Metzger R, Dees EC et al (2005) American Joint Committee on Cancer tumor-node-metastasis stage after neoadjuvant chemotherapy and breast cancer outcome. J Natl Cancer Inst 97:1137–1142
Chevallier B, Roche H, Olivier JP, Chollet P, Hurteloup P (1993) Inflammatory breast cancer. Pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rate. Am J Clin Oncol 16:223–228
Davidson NE, Morrow M (2005) Sometimes a great notion – an assessment of neoadjuvant systemic therapy for breast cancer. J Natl Cancer Inst 97:159–161
Fisher ER, Wang J, Bryant J, Fisher B, Mamounas E, Wolmark N (2002) Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18. Cancer 95:681–695
Kennedy S, Merino MJ, Swain SM, Lippman ME (1990) The effects of hormonal and chemotherapy on tumoral and nonneoplastic breast tissue. Hum Pathol 21:192–198
Langer F, Luck HJ, Kreipe HH (2004) Morphological response to therapy of breast carcinoma. Pathologe 25:455–460
Morrow M, Strom EA, Bassett LW et al (2002) Standard for breast conservation therapy in the management of invasive breast carcinoma. CA Cancer J Clin 52:277–300
Morrow M, Strom EA, Bassett LW et al (2002) Standard for the management of ductal carcinoma in situ of the breast (DCIS). CA Cancer J Clin 52:256–276
Ogston KN, Miller ID, Payne S et al (2003) A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival. Breast 12:320–327
Pinder SE, Provenzano E, Earl H, Ellis IO (2007) Laboratory handling and histology reporting of breast specimens from patients who have received neoadjuvant chemotherapy. Histopathology 50:409–417
Sataloff DM, Mason BA, Prestipino AJ, Seinige UL, Lieber CP, Baloch Z (1995) Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome. J Am Coll Surg 180:297–306
Schneeweiss A, Katretchko J, Sinn HP et al (2004) Only grading has independent impact on breast cancer survival after adjustment for pathological response to preoperative chemotherapy. Anticancer Drugs 15:127–135
Schnitt SJ, Collins LC (2008) Biopsy Interpretation of the Breast. Wolters Kluwer, Philadelphia
Sharkey FE, Addington SL, Fowler LJ, Page CP, Cruz AB (1996) Effects of preoperative chemotherapy on the morphology of resectable breast carcinoma. Mod Pathol 9:893–900
Sinn HP, Schmid H, Junkermann H et al (1994) Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy. Geburtshilfe Frauenheilkd 54:552–558
Symmans WF, Peintinger F, Hatzis C et al (2007) Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. J Clin Oncol 25:4414–4422
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Sinn, HP., Böcker, W. (2013). Tumorregression. In: Klöppel, G., Kreipe, H., Remmele, W., Dietel, M. (eds) Pathologie. Pathologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-04564-6_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-04564-6_11
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-04563-9
Online ISBN: 978-3-642-04564-6
eBook Packages: Medicine (German Language)